Table 3.

Adjusted prevalence ratios (PR) using different cut-points for low AMH values

	AMH <1.0 ng/mL		AMH below 25th percentile*
	Model 1†	Model 2‡	Model 1†	Model 2‡
	PR (95% CI)	PR (95% CI)	PR (95% CI)	PR (95% CI)
SLE/CYC− vs comparison	1.68 (0.97 to 2.91)	1.62 (0.93 to 2.82)	1.55 (0.97 to 2.47)	1.55 (0.97 to 2.47)
SLE/CYC+ vs comparison	2.90 (1.45 to 5.78)	2.90 (1.29 to 6.51)	2.66 (1.59 to 4.45)	2.43 (1.40 to 4.22)
SLE/CYC+ vs SLE/CYC−	1.72 (0.91 to 3.24)	1.79 (0.81 to 3.95)	1.72 (1.09 to 2.70)	1.57 (0.94 to 2.61)

*25th percentile cut-point categories were assigned separately for those aged 22–34 and 35–40 years.

†Adjusting for age at interview (continuous).

‡Adjusting for age at interview (continuous), body mass index (underweight: <18.5 kg/m², normal weight: 18.5–<25 kg/m², overweight: 25–<30 kg/m² and obese: ≥30 kg/m²) and hormonal contraception in the previous 12 months.

AMH, anti-Müllerian hormone; CYC, cyclophosphamide.